Navigation Links
Dr. Dorin Panescu, NewCardio's Chief Technology Officer, Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology Society
Date:9/15/2009

and proprietary platform technology, and specifically our Visual3Dx(TM) solution currently in development," said Dr. Panescu. "The data presented at the EMBC'09 conference confirms our belief that the Visual3Dx(TM) will be a powerful diagnostic solution for the detection of ACS and will help save lives by accelerating diagnosis of acute MIs and provide urgent care doctors with improved diagnostic accuracy. In addition, I was deeply honored to receive this prestigious award from the IEEE. I continue to value my relationship with this important scientific organization."

The paper was co-authored by Dr. Bosko Bojovic and Dr. Hadzievski Ljupco, (NewCardio, Inc. Senior Consultants), Dr. Panescu, Dr. Samuel George, (NewCardio Senior Consultant), Dr. Ihor Gussak (Chief Medical Officer of NewCardio), Dr. Branislav Vajdic (Chief Executive Officer of NewCardio), Dr. Alexei Shvilkin (Beth Israel Deaconess Medical Center; Harvard Medical School), and Dr. Vladan Vukcevic (Clinical Center of Serbia).

Dr. Panescu holds more than 130 U.S. patents and has 70 published or pending U.S. patent applications. He was named NewCardio's Chief Technical Officer and Vice-President of Research and Development in October of 2008. He joined NewCardio from St. Jude Medical, Inc., a $4.1 billion medical technology and services company, where he most recently served as Director, Technology Development, for the Company's Cardiac Rhythm Management Division. Previously, he served as Vice President of Research and Development, Operations and Intellectual Property for Refractec, Inc. and as Senior Director of Systems Development for Boston Scientific Corporation, directing new product development for the Electrophysiology Division.

NewCardio recently launched its first product, QTinno(TM), a fully automatic cardiac safety solution for Thorough QT and Phase I studies in Drug Development. Simultaneously, the Company continues to develop Visual3Dx(TM
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. NephroGenex Announces Full Enrollment in New Pyridorin(TM) Clinical Trial - PYR 210
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. WorldHeart Appoints David Pellone Chief Financial Officer
4. Mediware Names Thomas K. Mann Chief Executive Officer
5. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
6. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Coalition America Announces Addition of Mollie Gordon Brown as Chief Strategy Officer
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
11. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... Real Time Pain Relief (RTPR), makers of the popular ... Big Sky PBR to sponsor The Fifth Annual Big Sky Professional Bull Riders Event ... product samples of their popular pain relief lotion and products at the family friendly event ...
(Date:7/2/2015)... ... 02, 2015 , ... Five individuals from Loma Linda University ... specialized disaster training. The team – composed of four clinicians and one administrative ... who attended the training, which is dedicated to preparing first responders for a ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... July 02, 2015 , ... AvePoint Public Sector, Inc., ... across platforms and devices, today announced it was named the recipient of the 2015 ... The award, given out by the Government Technology Research Alliance (GTRA), was presented June ...
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected through the ... interact with products in their everyday lives. Technology can now help homeowners gain more ... entertainment and safety, as well as making kitchen tasks simpler. , "Summer ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4
... at the University of Pennsylvania,s Abramson Cancer Center have ... activating the immune system to destroy the cancer,s scaffolding. ... patients with advanced pancreatic cancer, several of whose tumors ... the novel way in which they uncovered them -- ...
... , THURSDAY, March 24 (HealthDay News) -- Researchers ... shrink pancreatic tumors by targeting the tissue surrounding cancer ... on an experimental antibody that sparks the patient,s own ... tumors together. Although testing has so far been ...
... books contain messages about health, but 24.6% of these are ... by the Knowledge Management Unit at Baza Hospital (Granada), published ... of 844 health messages in primary and secondary school text ... underpinning these texts, and we classified them into three categories ...
... MRC Lifecourse Epidemiology Unit in Southampton, UK, have presented ... falls history, in addition to clinical risk factors (CRFs) ... the accuracy of fracture prediction models. The research findings ... & Osteoarthritis in Valencia, Spain. Using results from ...
... acupuncture - sometimes referred to as placebo - is ... in cancer patients undergoing radiotherapy, according to a study ... who received only standard care including medications for nausea, ... acupuncture groups. "The beneficial effects seem not to ...
... Research fellow at the Centre for Bone Research at ... Zanchetta, Research fellow at the Instituto de Investigaciones Metablicas ... of the 2011 ESCEO-AMGEN Fellowship. Awarded by ... Osteoporosis and Osteoarthritis (ESCEO) with support from Amgen, the ...
Cached Medicine News:Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 2Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 3Health News:Novel Treatment for Pancreatic Cancer Under Study 2Health News:Novel Treatment for Pancreatic Cancer Under Study 3Health News:Around 25 percent of health messages in Spanish text books are not based on scientific evidence 2Health News:Acupuncture is equally effective with simulated needles 2
(Date:7/2/2015)... MUMBAI , July 2, 2015 ... equity stake in ZAO "Biocom" in Russia ... foray into the Russian pharmaceutical market which recorded RUB 765 ... 10 pharmaceutical markets in the world in 2014 (IMS Health). ... growth and expected to continue with this trend, projecting ...
(Date:7/2/2015)... 2, 2015 The report "Silage ... Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), ... 2020", Silage Inoculants & Enzymes Market is expected to ... 4.0% from 2015 to 2020. Browse ... through 194 P ages and an ...
(Date:7/2/2015)... 2015 BGI gab heute bekannt, ... vom American College of Pathologists (CAP) akkreditiert ... erste klinische Next-Generation-Sequencing Labor, das in ... und somit die höchsten Standards an klinischer ... FDA - 21 CFR Part 11 konformen ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... BROWNE, MORGAN FREEMAN, SAMUEL L. JACKSON, GEORGE LOPEZ, ... Oct. 24 On Thursday, November 15, 2007,Artists for a ... benefit, at The Wiltern in Los Angeles. The evening combines,the ... -- from the personal,to the global -- and make a ...
... Support Preclinical Development of Intradigm,s ICS-283, ... Corporation, a,leading developer of targeted, systemic RNA ... demonstrated the company,s,TargeTran(TM) delivery system is capable ... small interfering RNAs (siRNAs) that suppress,tumor-induced angiogenesis ...
Cached Medicine Technology:Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 2Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 3Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice 2Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: